126 related articles for article (PubMed ID: 18368030)
1. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
Negishi K; Noiri E; Maeda R; Portilla D; Sugaya T; Fujita T
Kidney Int; 2008 Jun; 73(12):1374-84. PubMed ID: 18368030
[TBL] [Abstract][Full Text] [Related]
2. Fibrate prevents cisplatin-induced proximal tubule cell death.
Nagothu KK; Bhatt R; Kaushal GP; Portilla D
Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
[TBL] [Abstract][Full Text] [Related]
3. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
Negishi K; Noiri E; Sugaya T; Li S; Megyesi J; Nagothu K; Portilla D
Kidney Int; 2007 Aug; 72(3):348-58. PubMed ID: 17495861
[TBL] [Abstract][Full Text] [Related]
4. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
[TBL] [Abstract][Full Text] [Related]
5. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
Kamijo-Ikemori A; Sugaya T; Obama A; Hiroi J; Miura H; Watanabe M; Kumai T; Ohtani-Kaneko R; Hirata K; Kimura K
Am J Pathol; 2006 Oct; 169(4):1107-17. PubMed ID: 17003471
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
[TBL] [Abstract][Full Text] [Related]
7. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
[TBL] [Abstract][Full Text] [Related]
8. High glucose potentiates L-FABP mediated fibrate induction of PPARĪ± in mouse hepatocytes.
Petrescu AD; McIntosh AL; Storey SM; Huang H; Martin GG; Landrock D; Kier AB; Schroeder F
Biochim Biophys Acta; 2013 Aug; 1831(8):1412-25. PubMed ID: 23747828
[TBL] [Abstract][Full Text] [Related]
9. Renal L-type fatty acid--binding protein in acute ischemic injury.
Yamamoto T; Noiri E; Ono Y; Doi K; Negishi K; Kamijo A; Kimura K; Fujita T; Kinukawa T; Taniguchi H; Nakamura K; Goto M; Shinozaki N; Ohshima S; Sugaya T
J Am Soc Nephrol; 2007 Nov; 18(11):2894-902. PubMed ID: 17942962
[TBL] [Abstract][Full Text] [Related]
10. Urinary human L-FABP is a potential biomarker to predict COX-inhibitor-induced renal injury.
Tanaka T; Noiri E; Yamamoto T; Sugaya T; Negishi K; Maeda R; Nakamura K; Portilla D; Goto M; Fujita T
Nephron Exp Nephrol; 2008; 108(1):e19-26. PubMed ID: 18182783
[TBL] [Abstract][Full Text] [Related]
11. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of urinary L-type fatty acid-binding protein predicts histological severity of acute kidney injury.
Negishi K; Noiri E; Doi K; Maeda-Mamiya R; Sugaya T; Portilla D; Fujita T
Am J Pathol; 2009 Apr; 174(4):1154-9. PubMed ID: 19264903
[TBL] [Abstract][Full Text] [Related]
13. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage.
Yokoyama T; Kamijo-Ikemori A; Sugaya T; Hoshino S; Yasuda T; Kimura K
Am J Pathol; 2009 Jun; 174(6):2096-106. PubMed ID: 19435794
[TBL] [Abstract][Full Text] [Related]
15. L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules.
Nakamura K; Ito K; Kato Y; Sugaya T; Kubo Y; Tsuji A
Drug Metab Pharmacokinet; 2008; 23(4):271-8. PubMed ID: 18762714
[TBL] [Abstract][Full Text] [Related]
16. Renal liver-type fatty acid binding protein attenuates angiotensin II-induced renal injury.
Ichikawa D; Kamijo-Ikemori A; Sugaya T; Yasuda T; Hoshino S; Igarashi-Migitaka J; Hirata K; Kimura K
Hypertension; 2012 Oct; 60(4):973-80. PubMed ID: 22926951
[TBL] [Abstract][Full Text] [Related]
17. Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.
Li S; Nagothu KK; Desai V; Lee T; Branham W; Moland C; Megyesi JK; Crew MD; Portilla D
Kidney Int; 2009 Nov; 76(10):1049-62. PubMed ID: 19710628
[TBL] [Abstract][Full Text] [Related]
18. Urinary excretion of fatty acid-binding protein reflects stress overload on the proximal tubules.
Kamijo A; Sugaya T; Hikawa A; Okada M; Okumura F; Yamanouchi M; Honda A; Okabe M; Fujino T; Hirata Y; Omata M; Kaneko R; Fujii H; Fukamizu A; Kimura K
Am J Pathol; 2004 Oct; 165(4):1243-55. PubMed ID: 15466390
[TBL] [Abstract][Full Text] [Related]
19. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats.
Hagar H; Medany AE; Salam R; Medany GE; Nayal OA
Exp Toxicol Pathol; 2015 Feb; 67(2):133-41. PubMed ID: 25488130
[TBL] [Abstract][Full Text] [Related]
20. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
Matsui K; Kamijo-Ikemorif A; Sugaya T; Yasuda T; Kimura K
Am J Pathol; 2011 Mar; 178(3):1021-32. PubMed ID: 21356355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
